• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

    View/Open
    Accepted version (1007.Kb)
    Volume
    64
    Pagination
    1224 - 1231
    DOI
    10.1016/j.jhep.2016.01.029
    Journal
    JOURNAL OF HEPATOLOGY
    Issue
    6
    ISSN
    0168-8278
    Metadata
    Show full item record
    Authors
    Foster, GR; Irving, WL; Cheung, MCM; Walker, AJ; Hudson, BE; Verma, S; McLauchlan, J; Mutimer, DJ; Brown, A; Gelson, WTH
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/12876
    Collections
    • Centre for Immunobiology [921]
    Copyright statements
    © 2016 European Association for the Study of the Liver.
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.